Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane for long-term sedation in critically ill patients
NCT01802255Phase 3Withdrawn
- Start
- Mar 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sevoflurane in anxiety disorder, agitation. Planned start Mar 2013; status: withdrawn.
02
Drugs
sevoflurane
03
Conditions
anxiety disorderagitation
Beyond the preview
Go deeper on NCT01802255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802255.